A new heart risk model had raised questions about who should take statins. A new study to "right-size" yields a similar answer to the old model.

Epic’s AI overhaul promises to address EHR headaches for clinicians and patients

How AI provider tools will probably drive up health care costs

“The body can heal while the self remains disconnected”: a psychologist on the overlooked trauma of illness.

After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without long-promised treatments.

Two members of Congress and a veteran agree: The VA needs to keep up the momentum on psychedelics research.

Neuroscientists have long held that the brain reorganizes itself when a body part is amputated. A new study says that’s not the case.

Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly approved therapy.

The FDA's controversial rejection of a skin cancer therapy from Replimune Group has prompted Krystal Biotech to shut down of a clinical trial involvin...

And more biotech news brought to you by The Readout.